ASPirin for Acute Pneumonia in the elderlY (ASPAPY): protocol of a multicentre randomised double-blind placebo-controlled trial

ASPirin for Acute Pneumonia in the elderlY (ASPAPY): protocol of a multicentre randomised double-blind placebo-controlled trial

Introduction Acute pneumonia (AP) remains a leading cause of death in the older population. Excess risk of death after AP is partly due to cardiovascular (CV) events. We aim to evaluate whether aspirin at a preventive dose (100 mg daily) introduced at the acute phase of AP reduces 90-day mortality.M...

Full description

Saved in:
Bibliographic Details
Main Authors: Sylvain Diamantis, Lionel Piroth, Gaetan Gavazzi, Isabelle Fournel, Caroline Laborde, Eléa Ksiazek, Amelie Cransac, Guillaume Deschasse, Alain Putot, Patrick Manckoundia, Marion Cortier, Mortada Adjim, Amal Aidoud, Thomas Brunet, Tomasz Chroboczek, Michele Collart, Matthieu Coulongeat, Sarah Lelarge, Nadège Lemarie, Claire Roubaud-Baudron
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/5/e102768.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/15/5/e102768.full

Similar Items